Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte BLOG

Labcyte Genomics Symposium Edinburgh: John Innes Centre, UK
TUESDAY, MAY 09, 2017
linkedin twitter facebook |  16Shares

The John Innes Centre in Norwich, UK, presented information about the Engineering Nitrogen Symbiosis for Africa (ENSA) project at our recent Genomics Symposium in Edinburgh. The aim of the projects, according to Dr. Andy Breakspear, is to integrate the molecular pathways from legumes into cereal crops for better affordability and sustainability.


To achieve their goals, the team uses Golden Gate technology and an automated, multi-gene construct assembly pipeline to produce hundreds of sequence-validated constructs per week, achieving 100% accuracy. Dr. Breakspear explains how automation of the assembly workflow has exponentially increased the number of constructs possible to make per week, and that Labcyte’s Echo® Liquid Handlers and Access™ Workstations are fundamental to this new, accelerated pipeline.


This is an exciting application of synthetic biology to help the developing world and is funded by the Bill and Melinda Gates Foundation. You can watch Dr. Breakspear's presentation video here.